Mangoceuticals, Inc. Common Stock (MGRX) support and resistance · rev $456.0K
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
This page maps Mangoceuticals, Inc. Common Stock (MGRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
MGRX currently screens at market cap $16.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MGRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MGRX quote page for the session range and the stock page for the full model.
Not investment advice.